Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis
dc.contributor.author | Montgomery, S.T. | |
dc.contributor.author | Dittrich, A.S. | |
dc.contributor.author | Garratt, L.W. | |
dc.contributor.author | Turkovic, L. | |
dc.contributor.author | Frey, D.L. | |
dc.contributor.author | Stick, S.M. | |
dc.contributor.author | Mall, M.A. | |
dc.contributor.author | Kicic, Anthony | |
dc.date.accessioned | 2019-11-09T21:36:47Z | |
dc.date.available | 2019-11-09T21:36:47Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Montgomery, S.T. and Dittrich, A.S. and Garratt, L.W. and Turkovic, L. and Frey, D.L. and Stick, S.M. and Mall, M.A. et al. 2018. Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis. Journal of Cystic Fibrosis. 17 (6): pp. 715-722. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/76797 | |
dc.identifier.doi | 10.1016/j.jcf.2018.05.006 | |
dc.description.abstract |
© 2018 European Cystic Fibrosis Society Background: Little is known about the role of interleukin (IL)-1 in the pathogenesis of cystic fibrosis (CF) lung disease. This study investigated the relationship between IL-1 signalling, neutrophilic inflammation and structural lung changes in children with CF. Methods: Bronchoalveolar lavage fluid (BALf) from 102 children with CF were used to determine IL-1α, IL-1β, IL-8 levels and neutrophil elastase (NE) activity, which were then correlated to structural lung changes observed on chest computed tomography (CT) scans. Results: IL-1α and IL-1β were detectable in BAL in absence of infection, increased in the presence of bacterial infection and correlated with IL-8 (p < 0.0001), neutrophils (p < 0.0001) and NE activity (p < 0.01 and p < 0.001). IL-1α had the strongest association with structural lung disease (p < 0.01) in the absence of infection (uninfected: p < 0.01 vs. infected: p = 0.122). Conclusion: Our data associates IL-1α with early structural lung damage in CF and suggests this pathway as a novel anti-inflammatory target. | |
dc.language | English | |
dc.publisher | ELSEVIER SCIENCE BV | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Respiratory System | |
dc.subject | Airway epithelium | |
dc.subject | Hypoxia | |
dc.subject | Neutrophilic inflammation | |
dc.subject | Cystic fibrosis | |
dc.subject | Interleukin (IL)-1 | |
dc.subject | Mucus | |
dc.subject | MUCUS | |
dc.subject | BRONCHIECTASIS | |
dc.subject | ACTIVATION | |
dc.subject | CLEARANCE | |
dc.subject | SECRETION | |
dc.subject | EMPHYSEMA | |
dc.subject | THERAPY | |
dc.subject | INFANTS | |
dc.subject | CF | |
dc.title | Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis | |
dc.type | Journal Article | |
dcterms.source.volume | 17 | |
dcterms.source.number | 6 | |
dcterms.source.startPage | 715 | |
dcterms.source.endPage | 722 | |
dcterms.source.issn | 1569-1993 | |
dcterms.source.title | Journal of Cystic Fibrosis | |
dc.date.updated | 2019-11-09T21:36:47Z | |
curtin.department | School of Public Health | |
curtin.accessStatus | Fulltext not available | |
curtin.faculty | Faculty of Health Sciences | |
curtin.contributor.orcid | Kicic, Anthony [0000-0002-0008-9733] | |
dcterms.source.eissn | 1873-5010 | |
curtin.contributor.scopusauthorid | Kicic, Anthony [6507472922] |